These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2785850

  • 1. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
    Siena S, Bregni M, Formosa A, Brando B, Marenco P, Lappi DA, Bonadonna G, Gianni AM.
    Cancer Res; 1989 Jun 15; 49(12):3328-32. PubMed ID: 2785850
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates.
    Siena S, Lappi DA, Bregni M, Formosa A, Villa S, Soria M, Bonadonna G, Gianni AM.
    Blood; 1988 Aug 15; 72(2):756-65. PubMed ID: 3042047
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E.
    Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771
    [Abstract] [Full Text] [Related]

  • 4. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul 15; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 5. Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft.
    Siena S, Bregni M, Formosa A, Brando B, Lappi DA, Bonadonna G, Gianni AM.
    J Biol Regul Homeost Agents; 1989 Jul 15; 3(2):84-8. PubMed ID: 2479229
    [Abstract] [Full Text] [Related]

  • 6. B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.
    Bregni M, Siena S, Formosa A, Lappi DA, Martineau D, Malavasi F, Dorken B, Bonadonna G, Gianni AM.
    Blood; 1989 Feb 15; 73(3):753-62. PubMed ID: 2465042
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of growth of breast cancer cells in vitro by the ribosome-inactivating protein saporin 6.
    Gasperi-Campani A, Zoli W, Volpi A, Roncuzzi L, Amadori D.
    Anticancer Res; 1991 Feb 15; 11(2):1007-11. PubMed ID: 2064307
    [Abstract] [Full Text] [Related]

  • 8. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
    Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU.
    Br J Cancer; 2001 Feb 15; 84(4):571-8. PubMed ID: 11207056
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells.
    Piselli P, Vendetti S, Poccia F, Cicconi R, Mattei M, Bolognesi A, Stirpe F, Colizzi V.
    J Biol Regul Homeost Agents; 1995 Feb 15; 9(2):55-62. PubMed ID: 9127634
    [Abstract] [Full Text] [Related]

  • 10. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
    Dinota A, Tazzari PL, Michieli M, Visani G, Gobbi M, Bontadini A, Tassi C, Fanin R, Damiani D, Grandi M.
    Cancer Res; 1990 Jul 15; 50(14):4291-4. PubMed ID: 1694719
    [Abstract] [Full Text] [Related]

  • 11. Initial experience in treating human lymphoma with a combination of bispecific antibody and saporin.
    Bonardi MA, Bell A, French RR, Gromo G, Hamblin T, Modena D, Tutt AL, Glennie MJ.
    Int J Cancer Suppl; 1992 Jul 15; 7():73-7. PubMed ID: 1428411
    [Abstract] [Full Text] [Related]

  • 12. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
    Flavell DJ, Warnes SL, Bryson CJ, Field SA, Noss AL, Packham G, Flavell SU.
    Br J Haematol; 2006 Jul 15; 134(2):157-70. PubMed ID: 16771848
    [Abstract] [Full Text] [Related]

  • 13. The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.
    Polito L, Bolognesi A, Tazzari PL, Farini V, Lubelli C, Zinzani PL, Ricci F, Stirpe F.
    Leukemia; 2004 Jul 15; 18(7):1215-22. PubMed ID: 15103391
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
    Chen C, Li J, Micko CJ, Pierce GF, Cunningham MR, Lumsden AB.
    J Surg Res; 1998 Feb 15; 75(1):35-41. PubMed ID: 9614854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thermo-stability and antitumor activity on colon cancer cell lines of monoclonal anti-CEA antibody-saporin immunotoxin.
    Manosroi J, von Kleist S, Manosroi A, Grunert F.
    J Korean Med Sci; 1992 Jun 15; 7(2):128-35. PubMed ID: 1524725
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.